Literature DB >> 662030

Metabolic fate of 3H-noradrenaline released from the mouse hypothalamus.

E Adler-Graschinsky.   

Abstract

In slices of mouse hypothalamus labelled in vitro with 3H-noradrenaline (3-H-NA), the deaminated metabolite 3H-3,4-dihydroxyphenylglycol (3H-DOPEG), represented 40.2 +/- 2.6% of the total outflow of radioactivity and was the main fraction in the spontaneous efflux. Inhibition of neuronal monoamine oxidase by exposure to 60 micron bretylium, reduced the outflow of 3H-DOPEG to 9.7 +/0 0.3%. At the same time, the proportion of 3H-normetanephrine (3H-NMN) was significantly increased. On the other hand, an increased outflow of 3H-DOPEG and a lower proportion of 3H-NMN was obtained in the presence of 2.9 micron of the reserpine like agent Ro 4-1284. It is suggested that in the mouse hypothalamus, the deaminated metabolite, DOPEG, is formed inside the nerve terminals, while the O-methylated metabolite, NMN, might result from the activity of extraneuronal catechol O-methyltransferase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 662030     DOI: 10.1007/BF00508305

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  Urinary 3-methoxy-4-hydroxyphenylglycol production in mice and rats following intraventricular 6-hydroxydopamine.

Authors:  D R Howlett; F A Jenner; S R Nahorski
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

2.  Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system.

Authors:  S Z Langer
Journal:  Med Biol       Date:  1974-12

3.  Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium.

Authors:  R F Furchgott; P S Garcia; A R Wakade; P Cervoni
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

4.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

5.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

6.  Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria.

Authors:  E Adler-Graschinsky; S Z Langer; M C Rubio
Journal:  J Pharmacol Exp Ther       Date:  1972-02       Impact factor: 4.030

7.  Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.

Authors:  C Braestrup; M Nielsen
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

8.  Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat.

Authors:  M B Farah; E Adler-Graschinsky; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

9.  Studies on the metabolism of catecholamines in the central nervous system of the mouse.

Authors:  P M Ceasar; P Hague; D F Sharman; B Werdinius
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

  9 in total
  1 in total

1.  Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation.

Authors:  P P Li; J J Warsh; D D Godse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.